1. Market Research
  2. > Biotechnology Companies, April 2017

Biotechnology Companies, April 2017

24/7 Customer Support

Talk to Sam

+1 718 473 0872


About 4200 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 75 - $ 6995)

Frontier Pharma: Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products

Frontier Pharma: Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products

  • $ 6995
  • Industry report
  • March 2017
  • by GBI Research

Frontier Pharma: Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products Summary Fatty liver disease (FLD) comprises a spectrum of chronic ...

Synthetic Biology: Global Markets

January 2017 $ 6650

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.